Simultaneous whole-body protein breakdown (using '5N-glycine) and urinary 3-methylhistidine (3MH) excretion rates were determined in six hospitalized normal volunteers after 10 days of starvation and a subsequent 10-day period of total parental nutrition (TPN). These data were contrasted to whole-body protein breakdown and urinary 3 M H excretion in ten depleted (14.8% body weight loss) patients with benign intraabdominal disease studied in the basal (48 hours without nutrient intake) and intravenously refed states. The rates of whole-body protein breakdown were significantly reduced from basal (brief fasting or starvation) conditions in both nor~nal volunteers (p < 0.01) and depleted patients (p c 0.01) during TPN. The rate of protein catabolism normalized for creatinine excretion in patients was higher than that observed in normal subjects during both basal (p <0.05) and intravenous feeding conditions. Daily urinary 3 M H excretion was reduced during intravenous feeding in both starved normal volunteer (235 + 13 pmol/d to 197 f 9 /.~mol/d p < 0.05) and in depleted patients (209 f 31 pmol/d to 140 f 35 fimol/d), and an apparent linear relationship between protein breakdown and urinary 3MH, normalized for creatinine excretion, was obtained in both volunteer and patient (r = 0.85) populations during fasting-refeeding. However, separate regression analysis of the protein breakdown and 3 M H responses of both volunteer and patient groups under conditions of fasting, starvation, and refeeding revealed significant differences between volunteer and patient populations during intravenous refeeding (p < 0.01). Further analysis of 3 M H excretion in relationship to nitrogen balance during refeeding suggests a complex relationship between urinary 3 M H excretion and whole-body protein metabolism that may be partly related to the degree of antecedent malnutrition. I N THE ABSENCE of an acceptable method for the direct measurement of in vivo human muscle protein breakdown, the urinary excretion of 3-methylhistidine (3MH) has been widely applied to estimate muscle protein Preliminary evidence indicated that 3MH was present largely in actin13 and myosin,14 not reutilized or oxidized once released from tissue protein," and was excreted quantitatively in man. This suggested that urinary appearance of this amino acid could be used as an accurate, albeit indirect, determinant of muscle myofibrillar protein degradation in humans. The initial enthusiasm for this method has recently been tempered by experimental evidence that nonmuscle contributions of 3MH may contribute extensively to the 3MH production rate,l"I8 and by clinical observations of disparate rates of peripheral tissue 3MH efflux from urinary excretion.lg Resolution of this controversy is obscured by variations in clinical status which have often prevailed during the measurement of 3MH excretion. Such variables are particularly evident in studies where recent surgical or skeletal trauma may have induced disproportionate injury to 3MH-containing tissues, or where antecedent dietary factors may have influenced 3MH excretion rates.
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has been widely applied to estimate muscle protein Preliminary evidence indicated that 3MH was present largely in actin13 and myosin,14 not reutilized or oxidized once released from tissue protein," and was excreted quantitatively in man. This suggested that urinary appearance of this amino acid could be used as an accurate, albeit indirect, determinant of muscle myofibrillar protein degradation in humans. The initial enthusiasm for this method has recently been tempered by experimental evidence that nonmuscle contributions of 3MH may contribute extensively to the 3MH production rate,l"I8 and by clinical observations of disparate rates of peripheral tissue 3MH efflux from urinary excretion.lg Resolution of this controversy is obscured by variations in clinical status which have often prevailed during the measurement of 3MH excretion. Such variables are particularly evident in studies where recent surgical or skeletal trauma may have induced disproportionate injury to 3MH-containing tissues, or where antecedent dietary factors may have influenced 3MH excretion rates.
To examine 3MH excretion under conditions independent of both dietary and tissue-specific injury factors, we have evaluated the relationship of urinary 3MH appearance and whole-body protein breakdown in depleted normal subjects and cachectic patients with benign disease before and during nutritional repletion by total parenteral nutrition. The determination of experimental parameters under conditions of unstressed brief fasting, prolonged starvation, and intravenous refeeding permitted an evaluation of 3MH excretion over a wide range of whole-body protein breakdown.
